gee, I wonder why we even have to bother with a B for C trial? I mean, just look at those data for completely unrelated problems- cellulitis and distal ulcerative colitis? But we still have to prove B can help C patients?
Who could possibly suggest that Remdesivir would be great in the lab and so- so in real life? Oh- that has already been shown?